GSK

1,944.5

+1.07%↑

STJ

1,210

+2.07%↑

HIK

1,239

-0.56%↓

HILS

2,095

+3.71%↑

GSK

1,944.5

+1.07%↑

STJ

1,210

+2.07%↑

HIK

1,239

-0.56%↓

HILS

2,095

+3.71%↑

GSK

1,944.5

+1.07%↑

STJ

1,210

+2.07%↑

HIK

1,239

-0.56%↓

HILS

2,095

+3.71%↑

GSK

1,944.5

+1.07%↑

STJ

1,210

+2.07%↑

HIK

1,239

-0.56%↓

HILS

2,095

+3.71%↑

GSK

1,944.5

+1.07%↑

STJ

1,210

+2.07%↑

HIK

1,239

-0.56%↓

HILS

2,095

+3.71%↑

Search

Pets at Home Group Plc

Open

BrancheGesundheitswesen

178.8 3.05

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

156.8

Max

183.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

-24M

26M

Verkäufe

85M

778M

KGV

Branchendurchschnitt

11.182

57.833

EPS

0.056

Dividendenrendite

6.74

Gewinnspanne

3.366

Angestellte

11,597

EBITDA

8.3M

102M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+26.65% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

6.74%

2.47%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-75M

841M

Vorheriger Eröffnungskurs

175.75

Vorheriger Schlusskurs

178.8

Nachrichtenstimmung

By Acuity

29%

71%

76 / 350 Ranking in Healthcare

Pets at Home Group Plc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. März 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. März 2026, 22:55 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. März 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. März 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. März 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. März 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. März 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Global Equities Roundup: Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. März 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. März 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. März 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. März 2026, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. März 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. März 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. März 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. März 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. März 2026, 21:10 UTC

Wichtige Nachrichtenereignisse

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. März 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk
Ergebnisse
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Pets at Home Group Plc Prognose

Kursziel

By TipRanks

26.65% Vorteil

12-Monats-Prognose

Durchschnitt 230 GBX  26.65%

Hoch 265 GBX

Tief 195 GBX

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pets at Home Group Plc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

2 ratings

1

Buy

0

Halten

1

Sell

Stimmung

By Acuity

76 / 350 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pets at Home Group Plc

Pets at Home Group Plc engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom. It operates through three segments: Retail, Vet Group, and Central. The company offers pet grooming services comprising a full dog groom, bath and blow dry, microchipping, and nail clipping; and pet insurance products, as well as other in-store services, including consultations with its trained pet nutritionists. Further, it offers general veterinary care; triage; and veterinary telehealth services. The company operates through pet care centers, stores, general practices, and grooming salons. It also provides products and services through online under the Pet at Home, Vets for Pets, Pet Grooming, Pets Foundation, and Pets VIP Club brands. Pets at Home Group Plc was founded in 1991 and is based in Handforth, the United Kingdom.
help-icon Live chat